CFP
DXCM icon

Catalyst Financial Partners’s DexCom DXCM Stock Holding History

Catalyst Financial Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,244
Closed -$254K – 274
2024
Q2 		$254K Buy
2,244
+89
+4% +$11.3K 0.06% 208
2024
Q1 		$288K Buy
2,155
+84
+4% +$10.6K 0.07% 175
2023
Q4 		$257K Buy
+2,071
New +$212K 0.07% 185
2023
Q3 		– Sell
-1,946
Closed -$250K – 210
2023
Q2 		$250K Buy
1,946
+184
+10% +$22.3K 0.09% 164
2023
Q1 		$205K Buy
+1,762
New +$197K 0.09% 171

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Catalyst Financial Partners's DXCM Position: Q3 2024 in Review

Catalyst Financial Partners sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,244 shares — an estimated $254K sold.

Catalyst Financial Partners first reported a position in DXCM in Q1 2023 and held it in 5 quarters. The position peaked at $288K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Catalyst Financial Partners reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Catalyst Financial Partners sold 2,244 DexCom shares in Q3 2024, an estimated $254K.
  • Catalyst Financial Partners first reported a position in DexCom in Q1 2023 and held it in 5 quarters.
  • Catalyst Financial Partners's DexCom position peaked at $288K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Catalyst Financial Partners's 13F filing for Q3 2024, filed 28 Oct 2024.